Cytokinetics
Sue Willemann is an experienced business manager with a strong background in pharmaceutical sales and marketing. Currently serving as an Area Business Manager at Cytokinetics since May 2022, Willemann previously held significant roles at Biogen as Regional Sales Director, where efforts focused on building and launching an Alzheimer’s Division. With a history of leading high-performing sales teams, Willemann achieved national sales leadership at Lupin Pharmaceuticals and directed Specialty Account Managers at Nalpropion Pharmaceuticals in the obesity market. Prior experience includes roles at Orexigen Therapeutics, UnitedHealth Group, and Merck, where Willemann excelled in strategic account management, team management, and innovative promotional campaigns. Willemann holds a Bachelor of Science in Marketing from Villanova University and continued education at Fordham University.
This person is not in any offices
Cytokinetics
15 followers
Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators as potential treatments for people with diseases characterized by impaired or declining muscle function.